Label: SENNA-S- docusate sodium and sennosides capsule, gelatin coated

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph not final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated November 23, 2022

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • ACTIVE INGREDIENT

    Active ingredients (in each softgel)Purpose
    Docusate sodium 50 mgStool softener
    Sennosides 8.6 mgLaxative
  • Uses

    • relieves occasional constipation (irregularity)
    • generally produces bowel movement in 6-12 hours
  • Warnings

    Do not use

    • if you are now taking mineral oil, unless directed by a doctor
    • laxative products for longer than 1 week, unless directed by a doctor

    Ask a doctor before use if you have

    • stomach pain
    • nausea
    • vomiting
    • noticed a sudden change in bowel habits that lasts over 2 weeks

    Stop use and ask a doctor if

    • you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    • take preferably at bedtime or as directed by a doctor
    AgeStarting DosageMaximum Dosage
    adults and children 12 years of age or older2 softgels once a day4 softgels twice a day
    children 6 to under 12 years1 softgel once a day2 softgels twice a day
    children 6 years and underask a doctorask a doctor
  • Other information

    • each softgel contains: Sodium 3 mg
    • store at 25 °C (77 °F); excursions permitted between 15°-30 °C (59 °-86 °F)
  • Inactive ingredients

    Aerosil, beeswax, FD&C yellow #6, gelatin, glycerin, light liquid paraffin, polyethylene glycol-400, povidone (PVP K-30), propylene glycol, purified water, sodium carboxymethylcellulose, soya lecithin, sorbitol, titanium dioxide

  • Questions?

    Call 1-888-333-9792 Monday-Friday 9AM-5PM EST

  • SPL UNCLASSIFIED SECTION

    DISTRIBUTED BY: WALGREEN CO.
    200 WILMOT RD., DEERFIELD, IL 60015

  • PRINCIPAL DISPLAY PANEL - 60 Softgels Bottle Carton

    Walgreens

    Compare to Senokot-S®
    active ingredients††

    NDC 0363-3010-60

    Senna-S
    DOCUSATE SODIUM 50 mg /
    STOOL SOFTENER
    SENNOSIDES 8.6 mg / LAXATIVE

    SOFTGELS

    DUAL ACTION

    • Gently relieves constipation
    • Stool softener

    60 SOFTGELS

    ACTUAL SIZE

    image description

  • INGREDIENTS AND APPEARANCE
    SENNA-S 
    docusate sodium and sennosides capsule, gelatin coated
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0363-3010
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
    Inactive Ingredients
    Ingredient NameStrength
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    GELATIN (UNII: 2G86QN327L)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
    POVIDONE K30 (UNII: U725QWY32X)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    WATER (UNII: 059QF0KO0R)  
    SORBITOL (UNII: 506T60A25R)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    Product Characteristics
    Colororange (Opaque) Scoreno score
    ShapeCAPSULE (SOFTGEL) Size6mm
    FlavorImprint Code S62
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0363-3010-601 in 1 CARTON07/03/2018
    160 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart33403/01/2016
    Labeler - Walgreens (008965063)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!